“The Not-So-Standard Model: Reconsidering Agency-Head Review of Administrative Adjudication Decisions”
- Administrative Law
Administrative Law Review
2023
Washington University Law Review
2022
Yale Journal of Regulation: Notice and Comment
2022
Research Handbook on the Economics of Intellectual Property Law
2019
“Cannabis for Medical Use: FDA and DEA Regulation in the Hall of Mirrors”
- Health Law
Food and Drug Law Journal
2019
“A Functional Approach to Judicial Review of PTAB Rulings on Mixed Questions of Law and Fact”
- Intellectual Property and Antitrust
Iowa Law Review
2019
“Opting Into Device Regulation in the Face of Uncertain Patentability”
- Intellectual Property and Antitrust
- Law and Technology
Marquette Intellectual Property Law Review
2019
“Shifting Institutional Roles in Biomedical Innovation in a Learning Healthcare System”
- Law and Technology
- Health Law
Journal of International Economics
2018
Daedalus
2018
Oxford Handbook of Intellectual Property Law
2017
Science
2017
“Diagnostics Need Not Apply”
- Intellectual Property and Antitrust
- Law and Technology
Boston University Journal of Science & Technology Law
2015
“Patent Punting: How FDA and Antitrust Courts Undermine the Hatch-Waxman Act to Avoid Dealing with Patents”
- Intellectual Property and Antitrust
Michigan Telecommunications and Technology Law Review
2015
“Patents and Regulatory Exclusivity in the USA”
Encyclopedia of Health Economics
2014
“Prometheus Rebound: Diagnostics, Nature, and Mathematical Algorithms”
- Intellectual Property and Antitrust
Yale Law Journal Online
2013
“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”
- Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012
The Oxford Handbook of the Economics of the Biopharmaceutical Industry
2012
The Law and Theory of Trade Secrecy: A Handbook of Contemporary Research
2011
“Patent Costs and Unlicensed Use of Patented Inventions”
- Intellectual Property and Antitrust
University of Chicago Law Review
2011
“Costs, Norms, and Inertia: Avoiding an Anticommons for Proprietary Research Tools”
- Intellectual Property and Antitrust
Working Within the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2010
Science
2009
“Noncompliance, Nonenforcement, Nonproblem? Rethinking the Anticommons in Biomedical Research”
- Intellectual Property and Antitrust
Houston Law Review
2008
Lewis and Clark Law Review
2008
“Patents and the Progress of Science: Exclusive Rights and Experimental Use”
- Intellectual Property and Antitrust
The Economics of Innovation Policy
2008
Michigan Telecommunications and Technology Law Review
2007
“The Supreme Court and the Federal Circuit: Visitation and Custody of Patent Law”
- Intellectual Property and Antitrust
Michigan Law Review First Impressions
2007
Nature Biotechnology
2006
Industrial and Corporate Change
2006
“The Story of Diamond v. Chakrabarty: Technological Change and the Subject Matter Boundaries of the Patent System”
- Intellectual Property and Antitrust
Intellectual Property Stories
2006
“Harnessing and Sharing the Benefits of State-Sponsored Research: Intellectual Property Rights and Data Sharing in California’s Stem Cell Initiative”
- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2006
“How Can You Patent Genes?”
- Intellectual Property and Antitrust
Genetics: Science, Ethics and Public Policy: A Reader
2005
Yale Journal of Health Policy, Law, and Ethics
2005
New England Journal of Medicine
2005
Handbook of Stem Cells
2004
“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”
- Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004
Journal of Institutional and Theoretical Economics
2004
“Bayh-Dole Reform and the Progress of Biomedicine”
- Intellectual Property and Antitrust
American Scientist
2003
“Can Patents Deter Innovation? The Anticommons in Biomedical Research”
- Intellectual Property and Antitrust
Rights and Resources
2003
“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”
- Intellectual Property and Antitrust
Fordham Law Review
2003
“Bayh-Dole Reform and the Progress of Biomedicine”
- Intellectual Property and Antitrust
Law and Contemporary Problems
2003
Perspectives on Properties of the Human Genome Project
2003
Comptes rendus Biologies
2003
Science
2003
“Public vs. Proprietary Science: A Fruitful Tension?”
- Intellectual Property and Antitrust
Daedalus
2002
“Public vs. Proprietary Science: A Fruitful Tension?”
- Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002
“Can Patents Deter Innovation? The Anticommons in Biomedical Research”
- Intellectual Property and Antitrust
Perspectives on Property Law
2002
Academic Medicine: Journal of the Association of American Medical Colleges
2002